Status:
COMPLETED
Vocal in Assessment of Endometrium in Postmenopause
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Kasr El Aini Hospital
om almasreen hospital ,Egypt
Conditions:
Postmenopausal Bleeding
Eligibility:
FEMALE
50-80 years
Brief Summary
The unbalanced estrogen with no progesterone will lead to endometrial thickening .This thickening result in endometrial hyperplasia \& carcinoma and lead to irregular bleeding
Detailed Description
Recent advances in the screening and diagnosis of endometrial pathologies (eg,endometrial hyperplasia , endometrial carcinoma ,endometrial polyps and myomas ) are directed towards non invasive methods...
Eligibility Criteria
Inclusion
- Postmenopausal women who were Complaining of Post-menopausal vaginal bleeding.
Exclusion
- Women with hormone replacement therapy.
- Women showing intra-cavitary fluid collection at ultrasound examination
- Women with other gynecological lesions in the pelvis other than the uterus
- Previous diagnosis of endometrial pathology.
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 25 2018
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03404154
Start Date
January 18 2018
End Date
August 25 2018
Last Update
October 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Algazeerah
Giza, Egypt